霸王茶姬美股大跌！深夜回应“咖啡因”问题

Core Viewpoint - Bawang Chaji's stock price experienced a significant decline, dropping over 14% and reaching an all-time low since its listing, amid concerns regarding caffeine content in its products [2][3]. Stock Performance - As of the latest report, Bawang Chaji's stock price was at 11.610, with a high of 11.780 and a low of 10.260, reflecting a total trading volume of 3.96 million shares and a market value of 21.31 billion [3]. - The stock has seen a 52-week high of 41.800 and a low of 10.260, with a price-to-earnings ratio of 8.67 [3]. Caffeine Controversy - The topic of "Bawang Chaji caffeine" gained significant attention on social media, with users reporting adverse reactions such as palpitations and insomnia after consuming the products [4]. - In response, Bawang Chaji clarified that the caffeine content in their tea drinks is comparable to that of a latte and significantly lower than that of an Americano, emphasizing their use of whole leaf tea rather than lower-quality ingredients [5]. Legal Action - The company announced that it is aware of recent rumors and false information circulating online, and its legal department has initiated legal proceedings to protect its reputation [8]. Financial Performance - In the third quarter of 2025, Bawang Chaji reported a total of 7,338 global stores, with a gross merchandise volume (GMV) of 79.30 billion and net revenue of 32.08 billion, achieving a net profit of 5.03 billion, marking 11 consecutive quarters of profitability [10].